Urologix, Inc.
ULGX
$0.0001
$0.000.00%
| 03/31/2015 | 12/31/2014 | 09/30/2014 | 06/30/2014 | 03/31/2014 | |
|---|---|---|---|---|---|
| Net Income | -4.67M | -5.98M | -6.71M | -7.61M | -5.33M |
| Total Depreciation and Amortization | 501.00K | 535.00K | 564.00K | 587.00K | 616.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.63M | 4.36M | 4.34M | 4.33M | 1.39M |
| Change in Net Operating Assets | 274.00K | 412.00K | 843.00K | 1.16M | 477.00K |
| Cash from Operations | -263.00K | -678.00K | -966.00K | -1.53M | -2.85M |
| Capital Expenditure | -12.00K | -6.00K | -31.00K | -32.00K | -52.00K |
| Sale of Property, Plant, and Equipment | 9.00K | 5.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -1.37M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -58.00K | -58.00K | -9.00K | -10.00K | -15.00K |
| Cash from Investing | -61.00K | -59.00K | -40.00K | -42.00K | -1.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -1.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -324.00K | -737.00K | -1.01M | -1.57M | -4.28M |
